Delivery Order SPE2DB22D3301-SPE2DB25FX4AU

Award Date 10/20/24
Potential Completion Date 10/21/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,431.67 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with a completion date of May 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $25,169.58, is a delivery order for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $7,545.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2214|SPE2DB24FS5HL) with a firm fixed price, covering the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,978.32 firm fixed-price delivery order is for the supply of 4564709131 - GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,848.52, is for the delivery of 4565058820 GILENYA 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999...
This federal contract award, valued at $18,792.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, to support military...
This federal contract award, with ID SPE2DX15D3006|SPE2DX24F03US, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $19,541.72 firm fixed price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of July 9, 2024. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $14,899.49 firm fixed price delivery order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4AU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,130.03 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the information provided.

Generated 1/19/25, 9:06 AM